ong-term study of KW-6485P
Phase 2
- Conditions
- Symptomatic or cryptogenic localization related epilepsy
- Registration Number
- JPRN-jRCT2080220855
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients who have completed and been eligible for the pharmacokinetic study of KW-6485P for pediatric patients
Patients who have provided written informed consent from guardian
Exclusion Criteria
Patients who did not reliably complete their epileptic seizure record in the pharmacokinetic study of KW-6485P for pediatric patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method